变应性真菌性鼻-鼻窦炎免疫治疗现状

doi:10.6040/j.issn.1673-3770.1.2018.006

摘要/Abstract

摘要： 变应性真菌性鼻-鼻窦炎(AFRS)是一种真菌作为抗原接触特应性个体鼻黏膜后导致的变态反应性疾病,是Ⅰ型和Ⅲ型变态反应共同作用的结果。AFRS发病率较高,手术和术后药物治疗均容易复发,给患者生活质量带来严重影响,因此寻求安全有效的综合治疗方案显得尤为重要。作为AFRS综合治疗的一部分,免疫治疗可以显著改善AFRS患者临床症状,降低患者对皮质类固醇激素等药物的需要量,且无需反复施行手术,其临床效果是肯定的。但由于研究结果差异较大,该治疗方法仍有争议,还有待于在临床实践中进一步探索。

关键词: 鼻窦炎, 真菌, 免疫治疗, 变态反应

Abstract: Allergic fungal rhinosinusitis(AFRS)is an allergic disease caused by a fungus that acts as an antigen at the nasal mucosa of atopic individuals, and produces a combination of type I and III allergic reactions. The incidence of AFRS is high, and it is easy to relapse after surgery and postoperative drug treatment. There are serious impacts on the quality of life in patients. Therefore, it is of great importance to seek a safe and effective comprehensive treatment plan. Immunotherapy performed as part of comprehensive therapy can significantly improve the clinical symptoms of AFRS and reduce the requirement for corticosteroids and other drugs. The clinical value of immunotherapy is confirmed further by the finding that patients with AFRS who receive this treatment do not need repeat surgery. However, the benefits of immunotherapy remain controversial owing to conflicting research findings, and therefore these benefits warrant further investigation in clinical practice.

Key words: Allergy, Sinusitis, Fungi, Immunotherapy

中图分类号:

R765.4

覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26.

QIN Gang, LIANG Zhuoping. Status of immunotherapy in allergic fungal rhinosinusitis[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 23-26.

参考文献

[1] Collins MM, Nair SB, Wormald PJ. Prevalence of noninvasive fungal sinusitis in South Australia[J]. Am J Rhinol, 2003, 17(3):127-132.
[2] Raz E, Win W, Hagiwara M, et al. Fungal sinusitis[J]. Neuroimaging Clin N Am, 2015, 25(4):569-576.
[3] Luong A, Marple BF. Allergic fungal rhinosinusitis[J]. Curr Allergy Asthma Rep, 2004, 4(6):465-470.
[4] Schubert MS. Allergic fungal sinusitis[J]. Otolaryngol Clin North Am, 2004, 37(2):301-326.
[5] Lee SH, Cho WY, Cho JY. Submucosal endoscopy, a new era of pure natural orifice translumenal endoscopic surgery(NOTES)[J]. Clin Endosc, 2012, 45(1):4-10.
[6] Campbell JM, Graham M, Gray HC, et al. Allergic fungal sinusitis in children[J]. Ann Allergy Asthma Immunol, 2006, 96(2):286-290.
[7] Prasad R, Garg R, Sanjay, et al. Concomitant allergic bronchopulmonary aspergillosis and allergic fungal sinusitis[J]. Indian J Med Sci, 2007, 61(9):532-534.
[8] Correll DP, Luzi SA, Nelson BL. Allergic fungal sinusitis[J]. Head and Neck Pathol, 2015, 9(4):488-491.
[9] Marglani O. Update in the management of allergic fungal sinusitis[J]. Saudi Med J, 2014, 35(8):791-795.
[10] Callejas CA, Douglas RG. Fungal rhinosinusitis: what every allergist should know[J]. Clin Exp Allergy, 2013, 43(8):835-849.
[11] Abbaszadegan A, Nabavizadeh M, Hoseini Yekani A, et al. Comparison of endodontic treatment results yielded from using normal saline with IKI final rinse or NaOCl irrigation: a 30-month follow-up study[J]. Iran Endod J, 2013, 8(4):171-176.
[12] 刘定荣, 史余勇, 詹先进, 等. 鼻腔结构与真菌性上颌炎关系的CT影像学研究[J]. 山东大学耳鼻喉眼学报, 2016, 30(5):94-97. LIU Dingrong, SHI Yuyong, ZHAN Xianjin, et al. Computed tomographic analysis of the relationship between nasal structure and fungal maxillary inflammation[J]. J Otolaryngol Ophthalmol Shandong Univ, 2016, 30(5):94-97.
[13] Lee SY, Yoon SH, Song WJ, et al. Influence of chronic sinusitis and nasal polyp on the lower airway of subjects without lowerairway diseases[J]. Allergy Asthma Immunol Res, 2014, 6(4):310-315.
[14] Tang J, Liu S, Zhang L, et al. Correlation analysis of prognostic and pathological features of patients with chronic sinusitis and nasal polyps following endoscopic surgery[J]. Exp Ther Med, 2013, 6(1):167-171.
[15] 康宗辉,夏思文,胡献惠, 等. 鼻内镜下中鼻道联合泪前隐窝入路治疗真菌性上颌窦炎[J]. 山东大学耳鼻喉眼学报, 2016, 30(6):33-36. KANG Zonghui, XIA Siwen, HU Xianhui, et al. Combined middle meatus and prelacrimal recess approach for treatment of fungal maxillary sinusitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2016, 30(6):33-36.
[16] Luong A, Marple B. The role of fungi in chronic rhinosinusitis[J]. Otolaryngol Clin North Am, 2005, 38(6):1203-1213.
[17] Doellman MS, Dion GR, Weitzel EK, et al. Immunotherapy in allergic fungal sinusitis: the controversy continues. A recent review of literature[J]. Allergy Rhinol(Providence), 2013, 4(1):e32-e35.
[18] Schubert MS, Hutcheson PS, Graff RJ, et al. HLA-DQB1*03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders[J]. J Allergy Clin Immunol, 2004, 114(6):1376-1383.
[19] Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class Ⅱ regions in susceptibility or protection in allergic bronchopulmonary aspergillosis[J]. J Allergy Clin Immunol, 2000, 106(4):723-729.
[20] Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2002, 127(4):324-332.
[21] Gupta RP, Bahadur S, Thakar A, et al. Management protocols of Allergic Fungal Sinusitis[J]. Indian J Otolaryngol Head Neck Surg, 2007, 59(1):35-40.
[22] Dutre T, Al Dousary S, Zhang N, et al. Allergic fungal rhinosinusitis-more than a fungal disease?[J]. J Allergy Clin Immunol, 2013, 132(2):487-489.
[23] Hutcheson PS, Schubert MS, Slavin RG. Distinctions between allergic fungal rhinosinusitis and chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2010, 24(6):405-408.
[24] Ragab A, Samaka RM. Immunohistochemical dissimilarity between allergic fungal and nonfungal chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2013, 27(3):168-176.
[25] Luong A, Davis LS, Marple BF. Peripheral blood mononuclear cells from allergic fungal rhinosinusitis adults express a Th2 cytokine response to fungal antigens[J]. Am J Rhinol Allergy, 2009, 23(3):281-287.
[26] Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis[J]. Laryngoscope, 2004, 114(7):1242-1246.
[27] Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis[J]. Laryngoscope, 1998, 108(10):1485-1496.
[28] Huchton DM. Allergic fungal sinusitis: an otorhinolaryngologic perspective[J]. Allergy Asthma Proc, 2003, 24(5):307-311.
[29] Singh R, Hazarika P, Nayak DR, et al. A comparison of microdebrider assisted endoscopic sinus surgery and conventional endoscopic sinus surgery for nasal polypi[J]. Indian J Otolaryngol Head Neck Surg, 2013, 65(3):193-196.
[30] Noorbakhsh S, Barati M, Farhadi M, et al. Intensive care unit nosocomial sinusitis at the Rasoul Akram Hospital: Tehran, Iran, 2007-2008[J]. Iran J Microbiol, 2012, 4(3):146-149.
[31] Al-Hashel JY, Ahmed SF, Alroughani R, et al. Migraine misdiagnosis as a sinusitis, a delay that can last for many years[J]. J Headache Pain, 2013, 14(1):97.
[32] Noorian V, Motaghi A. Assessment of the diagnostic accuracy of limited CT scan of paranasal sinuses in the identification of sinusitis[J]. Iran Red Crescent Med J, 2012, 14(11):709-712.
[33] Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies[J]. Drugs, 2004, 64(4):363-374.
[34] Mabry RL, Marple BF, Mabry CS. Outcomes after discontinuing immunotherapy for allergic fungal sinusitis[J]. Otolaryngol Head Neck Surg, 2000, 122(1):104-106.
[35] Mabry RL, Mabry CS. Allergic fungal sinusitis: the role of immunotherapy[J]. Otolaryngol Clin North Am, 2000, 33(2):433-440.
[36] Hall AG, de Shazo RD. Immunotherapy for allergic fungal sinusitis[J]. Curr Opin Allergy Clin Immunol, 2012, 12(6):629-634.
[37] Melzer JM, Driskill BR, Clenney TL, et al. Sublingual immunotherapy for allergic fungal sinusitis[J]. Ann Otol Rhinol Laryngol, 2015, 124(10):782-787.
[38] Greenhaw B, de Shazo RD, Arnold J, et al. Fungal immunotherapy in patients with allergic fungal sinusitis[J]. Ann Allergy Asthma Immunol, 2011, 107(5):432-436.
[39] Ryan MW. Allergic fungal rhinosinusitis[J]. Otolaryngol Clin North Am, 2011, 44(3):697-710.
[40] Evans MO 2nd, Coop CA. Novel treatment of allergic fungal sinusitis using Omalizumab[J]. Allergy Rhinol(Providence), 2014, 5(3):172-174.

相关文章 15

[1]	冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2]	翟雪纯,边欣,陈敬彩,邓家钰,叶子,杨萍丽. 慢性额窦炎患者焦虑抑郁特点及横断面研究[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 35-43.
[3]	顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[4]	李康,李轩毅,刘稳. 慢性化脓性中耳炎合并外耳道真菌感染的诊断与治疗[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 23-30.
[5]	李阳松,袁发洋,杨艳,张田,喻国冻. 基于Web of Science进行生物制剂治疗慢性鼻窦炎文献计量学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 54-64.
[6]	杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[7]	熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[8]	许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[9]	黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[10]	张家齐,袁野,洪陈,顾敏,程雷,陆美萍. 基于孟德尔随机化的肠道菌群与慢性鼻窦炎鼻息肉的因果关系及代谢物中介研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 49-60.
[11]	张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[12]	张广玲,陈兴雪,武天义,孙占伟,王卫卫,李世超,王广科. Tespa1在慢性鼻窦炎伴鼻息肉中的表达及作用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 35-42.
[13]	曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[14]	王文晴,张丹,朱梦迪,王路阳,杨培培,孙思思,张秋敏,周慧. 慢性鼻窦炎伴鼻息肉复发手术时临床及组织病理学特征变化[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 46-53.
[15]	王奥维,时文杰. CRSwNP中医证型与TFH细胞相关因子的相关性研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 54-60.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed